2-121237813-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014553.3(TFCP2L1):c.898G>A(p.Val300Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014553.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152156Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000159 AC: 40AN: 250938Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135668
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461802Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 727198
GnomAD4 genome AF: 0.000368 AC: 56AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.000606 AC XY: 45AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2024 | The c.898G>A (p.V300M) alteration is located in exon 9 (coding exon 9) of the TFCP2L1 gene. This alteration results from a G to A substitution at nucleotide position 898, causing the valine (V) at amino acid position 300 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at